AI assistant
Sending…
MACROGENICS INC — Director's Dealing 2019
Jan 28, 2019
34129_dirs_2019-01-28_53701be3-0866-4563-87ae-0a477d46446e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2019-01-28
Reporting Person: Risser Eric Blasius (Sr VP & Chief Business Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-01-28 | Common Stock | M | 6000 | $0.94 | Acquired | 28309 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2019-01-28 | Employee stock option (right to buy) | $0.94 | M | 6000 | Disposed | 2019-03-23 | Common Stock (6000.0) | Direct |
Footnotes
F1: The transaction represents an exercise and hold of expiring options.
F2: 4,000 stock options were inadvertently omitted from the total amount of derivative securities beneficially owned and reported on the Form 4 filed by the reporting person on October 23, 2018. The amount in Table II, Column 9 reflects the corrected amount of derivative securities beneficially owned by the reporting person following the transaction reported herein.
More from MACROGENICS INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 12
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 24
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 18